Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01518413
Title Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Research Institute
Indications

rhabdomyosarcoma

neuroblastoma

osteosarcoma

Ewing sarcoma of bone

extraosseous Ewing sarcoma

brain cancer

sarcoma

Advanced Solid Tumor

Therapies

Irinotecan + Sorafenib

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.